Loading insider details...
Beta
Latest Form 4 (Feb 25, 2026): Disposition to Issuer of 338,282 IKT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 25, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Disposition to Issuer | 338,282 | n/a |
| Jan 7, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 900,117 | n/a |
| Feb 25, 2025 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 1,100,705 | n/a |
| May 23, 2023 | Zura Bio Ltd (ZURA) | Grant/Award | 162,060 | n/a |
| Jan 30, 2023 | Pulmatrix, Inc. (PULM) | Grant/Award | 1,700 | n/a |
| Jan 31, 2022 | Pulmatrix, Inc. (PULM) | Grant/Award | 22,100 | n/a |
| Feb 2, 2021 | Pulmatrix, Inc. (PULM) | Grant/Award | 15,000 | n/a |
| Jun 26, 2020 | Pulmatrix, Inc. (PULM) | Grant/Award | 30,000 | n/a |